Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2020
Historique:
received: 06 06 2019
revised: 05 02 2020
accepted: 12 02 2020
pubmed: 1 3 2020
medline: 27 3 2021
entrez: 1 3 2020
Statut: ppublish

Résumé

Huntington's disease (HD) is an inherited, autosomal dominant disorder that is characteristically thought of as a degenerative disorder. Despite cellular and molecular grounds suggesting HD could also impact normal development, there has been scarce systems-level data obtained from in vivo human studies supporting this hypothesis. Sulcus-specific morphometry analysis may help disentangle the contribution of coexisting neurodegenerative and neurodevelopmental processes, but such an approach has never been used in HD. Here, we investigated cortical sulcal depth, related to degenerative process, as well as cortical sulcal length, related to developmental process, in early-stage HD and age-matched healthy controls. This morphometric analysis revealed significant differences in the HD participants compared with the healthy controls bilaterally in the central and intra-parietal sulcus, but also in the left intermediate frontal sulcus and calcarine fissure. As the primary visual cortex is not connected to the striatum, the latter result adds to the increasing in vivo evidence for primary cortical degeneration in HD. Those sulcal measures that differed between HD and healthy populations were mainly atrophy-related, showing shallower sulci in HD. Conversely, the sulcal morphometry also revealed a crucial difference in the imprint of the Sylvian fissure that could not be related to loss of grey matter volume: an absence of asymmetry in the length of this fissure in HD. Strong asymmetry in that cortical region is typically observed in healthy development. As the formation of the Sylvian fissure appears early in utero, and marked asymmetry is specifically found in this area of the neocortex in newborns, this novel finding likely indicates the foetal timing of a disease-specific, genetic interplay with neurodevelopment.

Identifiants

pubmed: 32113174
pii: S2213-1582(20)30048-6
doi: 10.1016/j.nicl.2020.102211
pmc: PMC7044794
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102211

Subventions

Organisme : Medical Research Council
ID : MR/K006673/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing financial interests.

Références

Exp Neurol. 1998 Dec;154(2):663-72
pubmed: 9878201
Brain. 2002 Aug;125(Pt 8):1815-28
pubmed: 12135972
Cereb Cortex. 2008 Mar;18(3):571-83
pubmed: 17584852
Trends Neurosci. 2000 Dec;23(12):599-605
pubmed: 11137149
Neuroimage. 2006 Oct 1;32(4):1562-75
pubmed: 16875847
J Anat Physiol. 1907 Jul;41(Pt 4):293-301
pubmed: 17232741
Neuroimage. 2004 Aug;22(4):1732-43
pubmed: 15275929
J Neurosci. 2010 Mar 3;30(9):3271-5
pubmed: 20203186
Neurology. 1979 Jan;29(1):1-3
pubmed: 154626
Neurology. 2012 Aug 14;79(7):621-2
pubmed: 22815547
Handb Clin Neurol. 2017;144:69-91
pubmed: 28947127
J Cogn Neurosci. 2014 Jan;26(1):96-106
pubmed: 23915057
Brain Lang. 2004 Apr;89(1):122-35
pubmed: 15010244
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1208-13
pubmed: 25583500
Neuroimage. 2004;23 Suppl 1:S129-38
pubmed: 15501082
J Neural Transm (Vienna). 2007 Mar;114(3):367-72
pubmed: 17024326
Hum Brain Mapp. 2005 Nov;26(3):210-20
pubmed: 16161162
Neurodegener Dis. 2013;12(1):23-35
pubmed: 22922585
Cereb Cortex. 2012 May;22(5):1038-51
pubmed: 21765181
Neurosci Lett. 1991 Dec 9;133(2):257-61
pubmed: 1840078
Am J Psychiatry. 2007 Sep;164(9):1428-34
pubmed: 17728429
Neurol Med Chir (Tokyo). 2005 Jan;45(1):1-17
pubmed: 15699615
Cereb Cortex. 2008 Jun;18(6):1444-54
pubmed: 17934189
Mov Disord. 2006 Dec;21(12):2140-4
pubmed: 17029272
Neurology. 2005 Sep 13;65(5):745-7
pubmed: 16157910
Brain. 2011 Jan;134(Pt 1):137-42
pubmed: 20923788
Mov Disord. 1996 Mar;11(2):136-42
pubmed: 8684382
Brain Pathol. 2015 Nov;25(6):701-11
pubmed: 25495445
Neurobiol Aging. 2015 Nov;36(11):2932-2939
pubmed: 26256787
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21900-5
pubmed: 19955426
Mov Disord. 2015 Feb;30(2):238-44
pubmed: 25545969
Neurology. 2004 Nov 9;63(9):1640-6
pubmed: 15534249
Neurology. 2002 Mar 12;58(5):695-701
pubmed: 11889230
Brain. 2008 Apr;131(Pt 4):1057-68
pubmed: 18337273
Neuroimage Clin. 2017 Oct 25;17:312-324
pubmed: 29527479
Neurology. 2012 Aug 14;79(7):668-74
pubmed: 22815549
J Alzheimers Dis. 2012;29(3):605-13
pubmed: 22297645
Neuroimage. 2010 Aug 1;52(1):32-42
pubmed: 20362679
Brain. 2008 Aug;131(Pt 8):2028-41
pubmed: 18587151
Hum Brain Mapp. 2013 Mar;34(3):519-29
pubmed: 22102212
Brain. 2019 Oct 1;142(10):2938-2947
pubmed: 31504236
Med Image Anal. 2002 Jun;6(2):77-92
pubmed: 12044997
Mov Disord. 2015 Apr 15;30(5):655-61
pubmed: 25820811
IEEE Trans Med Imaging. 2007 Apr;26(4):553-65
pubmed: 17427742
Neuroimage Clin. 2014 Mar 25;4:593-603
pubmed: 24936410

Auteurs

Jean-Francois Mangin (JF)

Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France.

Denis Rivière (D)

Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France.

Edouard Duchesnay (E)

Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France.

Yann Cointepas (Y)

Université Paris-Saclay, CEA, CNRS, Baobab, Neurospin, Gif-sur-Yvette, France.

Véronique Gaura (V)

Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Département des Sciences du Vivant (DSV), Institut d'Imagerie Biomédicale (I2BM), MIRCen, France.

Christophe Verny (C)

Centre national de référence des maladies neurogénétiques, Service de neurologie, CHU, 49000 Angers, France, UMR CNRS 6214 - INSERM U1083, France.

Philippe Damier (P)

CHU Nantes, INSERM, CIC 0004, France.

Pierre Krystkowiak (P)

Neurologie, CHU Amiens-Picardie, France.

Anne-Catherine Bachoud-Lévi (AC)

AP-HP, Hôpital Henri Mondor, Centre de Référence-Maladie de Huntington, France.

Philippe Hantraye (P)

MIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, France.

Philippe Remy (P)

Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Département des Sciences du Vivant (DSV), Institut d'Imagerie Biomédicale (I2BM), MIRCen, France.

Gwenaëlle Douaud (G)

Functional Magnetic Resonance Imaging of the Brain (FMRIB) Centre, Wellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom. Electronic address: gwenaelle.douaud@ndcn.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH